• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development of the Bhas42 cell transformation assay incorporating the human hepatic metabolic system for predicting a carcinogenicity of chemicals via hepatic metabolism

Research Project

Project/Area Number 15K08063
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Environmental and hygienic pharmacy
Research InstitutionKanagawa Institute of Industrial Sclence and Technology (2017)
Kanagawa Academy of Science and Technology (2015-2016)

Principal Investigator

Hirooka Takashi  地方独立行政法人神奈川県立産業技術総合研究所, 食品機能性評価グループ, 研究員(任期有) (50397519)

Co-Investigator(Kenkyū-buntansha) 大森 清美  神奈川県衛生研究所, 理化学部, 主任研究員 (20416069)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords発がん性予測試験 / 細胞形質転換試験 / Bhas42 細胞 / 肝代謝 / ヒト肝細胞株 / 発がんプロモーター / 代謝活性化 / CYP酵素 / Bhas42細胞 / 発がんイニシエーター / 発がんプロモーション / 発がんイニシエーション
Outline of Final Research Achievements

The Bhas42 cell transformation assay (Bhas42 CTA) has been internationally certified as an in vitro test method for predicting of chemical carcinogenicity. The purpose of this study is the development of the cell transformation assay using Bhas42 cells co-cultured with human hepatocytes for predicting the carcinogenicity of chemicals metabolized by hepatic metabolism system. We made the modified Bhas42 CTA medium, in which the CYP 3A4 activity of the human hepatocyte could be maintained at a detectable level for 10 days. Moreover, significantly increase in the formation of focus wasn’t observed in Bhas42 cells cultured with the modified CTA medium in the absence of test chemicals. On the other hand, we showed the expression of CYP1A1, 1A2 and 2B6 in Bhas42 cells by western blot analysis and CYP activity assay, and further demonstrated the contribution of CYP activities to focus formation of Bhas42 cells in initiation assay of 3-methylcholanthrene.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (7 results)

All 2017 Other

All Presentation (2 results) Remarks (5 results)

  • [Presentation] Bhas42細胞の薬物代謝酵素CYP発現解析と化学物質による細胞形質転換誘導における役割2017

    • Author(s)
      廣岡孝志,阿部啓子,大森清美
    • Organizer
      日本薬学会第137年会
    • Place of Presentation
      仙台国際センター
    • Year and Date
      2017-03-24
    • Related Report
      2016 Research-status Report
  • [Presentation] 3-methylcholanthreneによるBhas42細胞の形質転換フォーカス形成における薬物代謝酵素CYP1A1,1A2および2B6の寄与2017

    • Author(s)
      廣岡孝志 阿部啓子 大森清美
    • Organizer
      日本動物実験代替法学会第30回大会
    • Related Report
      2017 Annual Research Report
  • [Remarks] 地方独立行政法人 神奈川県立産業技術総合研究所

    • URL

      https://www.kanagawa-iri.jp/

    • Related Report
      2017 Annual Research Report
  • [Remarks] ヘルスケア・ニューフロンティア推進本部室 神奈川県ホームページ

    • URL

      http://www.pref.kanagawa.jp/div/0121/

    • Related Report
      2017 Annual Research Report
  • [Remarks] 地方独立行政法人 神奈川県立産業技術総合研究所

    • Related Report
      2016 Research-status Report
  • [Remarks] ヘルスケア・ニューフロンティア推進本部室 神奈川県ホームページ

    • URL

      http://www.pref.kanagawa.jp/div/0121/

    • Related Report
      2016 Research-status Report
  • [Remarks] 公益財団法人神奈川科学技術アカデミー

    • URL

      https://www.newkast.or.jp/index.html

    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi